PRESS RELEASE published on 03/06/2024 at 15:15, 2 years 6 months ago SYNLawn(R) Enhances Product Technology With SYNSport(TM) Powered by Trionic Plus(TM) SYNLawn® introduces SYNSport™ powered by Trionic Plus™ technology, a softer, stronger, and longer-lasting artificial grass variety. Key features include sharkskin friction reduction and entanglement technology for superior strength SYNLawn SYNSport Trionic Plus Technology Artificial Grass Sustainable Surfacing
Published on 09/11/2026 at 13:00, 43 minutes ago Silver Tiger Intersects 2.1 Metres of 7.72 Kilograms Per Tonne Silver Equivalent in the Caleigh Vein Including 0.53 Metres of 29.62 Kilograms
Published on 09/11/2026 at 04:00, 9 hours 43 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 15 hours 18 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 22 hours 23 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/11/2026 at 13:36, 6 minutes ago Vulcan secures second lithium production licence for Lionheart Project
Published on 09/11/2026 at 13:30, 13 minutes ago La Vaudoise construit un nouvel immeuble résidentiel innovant et pose sa première pierre à Zurich
Published on 09/11/2026 at 13:27, 15 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 09/11/2026 at 13:24, 18 minutes ago EQS-Adhoc: PAUL Tech AG: PAUL Tech AG seeks a two-year extension of the term of the EUR 35 million bond
Published on 09/11/2026 at 13:00, 42 minutes ago Gastech 2026: The Global Energy Industry Arrives in Bangkok as Asia Drives the Next Chapter of Energy Growth
Published on 09/11/2026 at 07:00, 6 hours 43 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 6 hours 43 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 6 hours 43 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 18 hours 13 minutes ago Availability of the 2026 Interim Financial Report